Jumpstarting Brain Tumor Drug Development
National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease. Specifically, the FDA offered their support to: Assist the National Brain […]
June 25, 2013